Screener / SEC EDGAR /CIK 0001755672 /10-K filed Feb 12, 2026, compared with Feb 14, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Consumer staples · Agriculture

Corteva, Inc. CTVA

Compare with peers Embed
The 10-K against last year's

159 changes: 12 added, 16 removed, 128 reworded, 3 quiet changes

10-K Feb 12, 2026 vs Feb 14, 2025

10-K 0001755672-26-000004 (Feb 12, 2026) vs 10-K 0001755672-25-000005 (Feb 14, 2025)

Every paragraph, and how much of it changed

One bar per paragraph, in the order of the 10-K. Height and colour show the share of its words not in the closest paragraph a year earlier; the tallest bars are new paragraphs.

Risk Factors

105 paragraphs · 10 new · 28 reworded · 6 gone · 10-K Feb 12, 2026 against Feb 14, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 52 · 37% changed Every version of it
Corteva faces risks arising from various unasserted and asserted litigation matters arising out of the normal course of its current and former business operations, including intellectual property, commercial, product liability, environmental and antitrust lawsuits. Corteva has noted a trend in public and private suits being filed on behalf of states, counties, cities and utilities alleging harm to the general public and the environment, including waterways and watersheds. Claims alleging harm to the public and the environment may be brought against Corteva, notwithstanding years of scientific evidence and regulatory determinations supporting the safety of crop protection products. The litigation involving Monsanto’s Roundup® non-selective glyphosate containing weedkiller products has resulted in negative publicity and sentiment and may lead to similar suits with respect to glyphosate-containing products and/or other established crop protection products. Claims and allegations that Corteva’s products or products that Corteva manufactures or markets on behalf of third parties are not safe could result in litigation, damage to Corteva’s reputation and have a material adverse effect on Corteva’s business. It is not possible to predict the outcome of these various proceedings and any potential impact on Corteva. An adverse outcome in any one or more of these matters may result in losses not fully covered by Corteva's insurance policies, and could be material to Corteva's financial results. Various factors or developments can lead to changes in current estimates of liabilities. Such factors and developments may include, but are not limited to, additional data, safety or risk assessments, as well as a final adverse judgment, significant settlement or changes in applicable law. A future adverse ruling or unfavorable development could result in future charges that could have a material adverse effect on Corteva.
Paragraph 17 · 36% changed Every version of it
In many markets there are various pressures to reduce government subsidies to farmers, which may inhibit the growth in these markets of products used in agriculture. In addition, government programs that provide financial support or create incentives for farmers, including those established by the U.S. Farm Bill, can be temporary in nature, or may be modified or discontinued. However, it is difficult to predict accurately whether, and if so when, such changes will occur. Corteva expects that the policies of governments and international organizations will continue to affect the planting choices made by growers as well as the income available to growers to purchase products used in agriculture and, accordingly, the operating results of the agriculture industry.
Paragraph 71 · 33% changed Every version of it
Through Corteva's ownership of EIDP, Corteva maintains EIDP defined benefit pension and other post-employment benefit plans. For some of these plans, including EIDP’s principal U.S. pension plan, Corteva continues as sponsor for the entire plan regardless of whether participants, including retirees, are or were associated with EIDP’s agriculture business. Corteva uses many assumptions in calculating its expected future payment obligations under these plans. Significant adverse changes in credit or market conditions could result in actual rates of returns on pension investments being lower than assumed. In addition, expected future payment obligations may be adversely impacted by changes in assumptions regarding participants, including retirees. In 2025, 2026, Corteva expects to contribute approximately $40 million to its pension plans other than the principal U.S. pension plan, and about $105 approximately $100 million for its other post-employment benefit ("OPEB") plans. While not there is no anticipated required contribution for 2025, 2026, Corteva may make expects to evaluate making discretionary contributions to the principal U.S. pension plan. Corteva, furthermore, plan and/or may be required to make significant contributions to its pension plans in the future, which future. These contributions could be significant and adversely affect Corteva’s results of operations, liquidity and financial condition.
Paragraph 70 · 32% changed Every version of it
Through Corteva's ownership of EIDP, Corteva maintains the EIDP defined benefit pension and other post-employment benefit plans. For some of these plans, including EIDP’s principal U.S. pension plan, Corteva continues as sponsor for the entire plan regardless of whether participants, including retirees, are or were associated with EIDP’s agriculture business. Corteva uses many assumptions in calculating its the expected future payment obligations under these plans. Significant adverse changes in credit or market conditions could result in actual rates of returns on pension investments being lower than assumed. In addition, expected future payment obligations may be adversely impacted by changes in assumptions regarding participants, including retirees. In 2025, Corteva expects to contribute approximately $40 million to its pension plans other than the principal U.S. pension plan, and about $105 million for its other post-employment benefit ("OPEB") plans. While not anticipated for 2025, Corteva may make discretionary contributions to the principal U.S. pension plan. Corteva, furthermore, may be required to make significant contributions to its pension plans in the future, which could adversely affect Corteva’s results of operations, liquidity and financial condition.
Paragraph 89 · 30% changed Every version of it
The company is dependent to a certain extent on DuPont and Dow to maintain and enforce certain of the intellectual property licensed under the Intellectual Property Cross-License Agreements. For example, DuPont and Dow are responsible for filing, prosecuting and maintaining (at their respective discretion) patents on trade secrets and know-how that they each respectively license to Corteva. They also have the first right to enforce their respective trade secrets and know-how licensed to Corteva. If DuPont or Dow, as applicable, fails to fulfill its obligations or chooses to not enforce the licensed patents, trade secrets or know-how under the Intellectual Property Cross-License Agreements, the company may not be able to prevent competitors from making, using and selling competitive products and services.
Paragraph 41 · 25% changed Every version of it
Additionally, Corteva’s ability to export its products and its sales outside the United States has been, and may continue to be adversely affected by significant changes in trade, tax or other policies, including the risk that other countries may retaliate through retaliating by purchasing less from the United States and the imposition of their own trade restrictions and/or increased tariffs in response to substantial changes to U.S. tariff, trade and tax policies, policies. Furthermore, significant changes in trade, tax, and other related policies or enforcement may pose business and financial risks, including those being evaluated by raising the Trump administration. cost of manufacturing inputs and altering customer demands.
Paragraph 18 · 25% changed Every version of it
In many markets there are various pressures to reduce government subsidies to farmers, which may inhibit the growth in these markets of products used in agriculture. In addition, government programs that create incentives for farmers, including those established by the U.S. Farm Bill, may be modified or discontinued. However, it is difficult to predict accurately whether, and if so when, such changes will occur. Corteva expects that the policies of governments and international organizations will continue to affect the planting choices made by growers as well as the income available to growers to purchase products used in agriculture and, accordingly, the operating results of the agriculture industry.
Paragraph 88 · 20% changed Every version of it
The company is dependent to a certain extent on DuPont and Dow to maintain and enforce certain of the intellectual property licensed under the Intellectual Property Cross-License Agreements. For example, DuPont and Dow are responsible for filing, prosecuting and maintaining (at their respective discretion) patents on trade secrets and know-how that they each respectively license to Corteva. They also have the first right to enforce their respective trade secrets and know-how licensed to Corteva. If DuPont or Dow, as applicable, fails to fulfill its obligations or chooses to not enforce the licensed patents, trade secrets or know-how under the Intellectual Property Cross-License Agreements, the company may not be able to prevent competitors from making, using and selling competitive products and services.

MD&A

252 paragraphs · 2 new · 116 reworded · 10 gone · 10-K Feb 12, 2026 against Feb 14, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 6 · 49% changed
Additionally, there may be other risks and uncertainties that the company is unable to currently identify or that the company does not currently expect to have a material impact on its business. Where, in any forward-looking statement or other estimate, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of the company's management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. The company disclaims and does not undertake any obligation to update or revise any forward-looking statement, except as required by applicable law. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled “Risk Factors” (Part I, Item 1A of this Form 10-K).
Paragraph 111 · 48% changed
2.Incremental 3.Incremental (gains) losses associated with activities related to the 2022 Restructuring Actions. Within (gain) loss on sale of business, assets and equity investments, such benefits are $(14) million, $(7) million and $(14) million for the years ended December 31, 2025, 2024 and 2023, respectively.
Paragraph 115 · 46% changed
7.Relates to a charge to increase the remediation accrual at the AltEn facility relating to Corteva's estimated voluntary contribution to the solid waste and wastewater remedial action plans. See Note 16 15 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, for further discussion. additional information.
Paragraph 252 · 46% changed
Extreme and volatile weather due to events, which may be amplified by, or become more frequent with, climate change may have an adverse impact on our customers’ ability to use the company's products and seed supply, potentially reducing sales volumes, revenues and margins. The company continuously evaluates These events may also shift or exacerbate existing pest and disease pressures. These pressures, along with the desire for climate-smart and climate-resilient technologies may present opportunities for existing and new product and service offerings the company to meet these shifting demands. Therefore, the anticipated demands of climate-smart company invests in enabling innovation that can create a more resilient agriculture value chain, while also working to reduce greenhouse gas emissions through cost effective operational improvements.
Paragraph 112 · 45% changed
3.Incremental loss 4.Incremental (gains) losses associated with activities related to the Crop Protection Operations Strategy Restructuring Program. Within (gain) loss on sale of business, assets and equity investments, a $(23) million benefit was recorded for the year ended December 31, 2025.
Paragraph 101 · 44% changed
The price decline was primarily due to market dynamics in Latin America. Unfavorable currency impacts were led by the Brazilian Real and Turkish Lira. The increase in volumes was driven by growth in Latin America on demand for new products and spinosyns, partially offset by unfavorable weather impacts in EMEA as well as just-in-time purchasing behavior in North America.
Paragraph 50 · 42% changed
Restructuring and asset related charges - net were $288 million for the year ended December 31, 2024, which was primarily comprised of a $232 million charge associated with the Crop Protection Operations Strategy Restructuring Program and a $55 million net charge from non-cash accelerated prepaid royalty amortization expense related to the Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits. The $232 million charge associated with the Crop Protection Operations Strategy Restructuring Program was primarily comprised of $91 million of severance and related benefit costs, $101 million of asset related charges, $10 million in decommissioning and demolition costs and $30 million of contract termination charges.
Paragraph 88 · 41% changed
The increase Pricing gains in price was broad-based and driven most regions, led by strong North America, demonstrate demand for top technology and operational execution globally, the strength of the portfolio, coupled with global corn and soybean prices up 14 percent and 7 percent, respectively. Pricing actions more than offset currency impacts in EMEA. The decline in volume increased out-licensing income. Volume growth was driven primarily by the 2022 decision to exit Russia, lower increased corn planted area in EMEA, reduced summer corn planted area and lower expected Safrinha corn planted area share gains in North America and Brazil, partially offset by increased corn acres lower soybean area in North America. Unfavorable The unfavorable currency impacts were led by the Turkish Lira and the Canadian Dollar.

A paragraph is matched with the one last year that shares the most of its words; under half in common makes it new. The paragraphs shown are the 8 reworded the most in each section.

The paragraph that changed most in each section

The redline

Marked against last year's 10-K: cut words struck through, new words highlighted.

MD&A214 words changed in this paragraph; it is 38% similar to last year's version.
Net sales were $17,226 $17,401 million for the year ended December 31, 2023, 2025, compared to $17,455 $16,908 million for the year ended December 31, 2022. 2024. The decrease increase was primarily driven by a 10 percent decrease in volume versus the prior year and a 1 percent unfavorable impact from currency, partially offset by a 7 percent increase in price and a 3 percent favorable portfolio and other increase in volume, partially offset by a 1 percent unfavorable currency impact. Volume declines Improvements in Crop Protection volume were driven by strategic product exits, Crop Protection channel inventory destocking, delayed farmer purchases, lower demand for new products and biologicals, while Seed experienced volume growth primarily due to increased corn planted area in EMEA, reduced summer corn planted area North America and lower expected Safrinha corn planted area in Brazil, Brazil. Pricing improvements were driven by Seed, led by North America and EMEA with continued execution on the Russia Exit, company's price for value strategy, partially offset by increased corn acres a decline in North Crop Protection pricing primarily due to the market dynamics in Latin America. The unfavorable currency impacts were led by the Turkish Lira, Canadian Dollar and Chinese Renminbi. Price gains were driven by continued execution on the company's price for value strategy, strong demand for new technology and strong execution in response to cost inflation led by EMEA, partially offset by challenging market dynamics in Latin America and North America. The portfolio and other impact was driven by the biologicals acquisitions and the sale of seeds already under production in Russia when the decision to exit the country was made and that the company was contractually required to purchase. Turkish Lira.

Source: Item 7, 10-K 0001755672-26-000004 vs Item 7, 10-K 0001755672-25-000005

Risk Factors179 words changed in this paragraph; it is 53% similar to last year's version.
Corteva faces risks arising from various unasserted and asserted litigation matters arising out of the normal course of its current and former business operations, including intellectual property, commercial, product liability, environmental and antitrust lawsuits. Corteva has noted a trend in public and private suits being filed on behalf of states, counties, cities and utilities alleging harm to the general public and the environment, including waterways and watersheds. Claims alleging harm to the public and the environment may be brought against Corteva, notwithstanding years of scientific evidence and regulatory determinations supporting the safety of crop protection products. The litigation involving Monsanto’s Roundup® non-selective glyphosate containing weedkiller products has resulted in negative publicity and sentiment and may lead to similar suits with respect to glyphosate-containing products and/or other established crop protection products. Claims and allegations that Corteva’s products or products that Corteva manufactures or markets on behalf of third parties are not safe could result in litigation, damage to Corteva’s reputation and have a material adverse effect on Corteva’s business. It is not possible to predict the outcome of these various proceedings and any potential impact on Corteva. An adverse outcome in any one or more of these matters may result in losses not fully covered by Corteva's insurance policies, and could be material to Corteva's financial results. Various factors or developments can lead to changes in current estimates of liabilities. Such factors and developments may include, but are not limited to, additional data, safety or risk assessments, as well as a final adverse judgment, significant settlement or changes in applicable law. A future adverse ruling or unfavorable development could result in future charges that could have a material adverse effect on Corteva.

Source: Item 1A, 10-K 0001755672-26-000004 vs Item 1A, 10-K 0001755672-25-000005

Legal Proceedings80 words changed in this paragraph; it is 64% similar to last year's version.
On September 27, 2023, Corteva filed a lawsuit in Delaware federal court against Inari Agriculture, Inc. and Inari Agriculture. N.V. (collectively “Inari”) asserting claims of Plant Variety Protection infringement, indirect patent infringement, breach of contract, and civil conversion. Corteva’s lawsuit alleges Inari illegally obtained various varieties of seed technologies from a seed depository and illegally transported them abroad for the purpose of performing gene editing on the technologies and then filing a patent for such technologies. In August 2024, the court denied Inari's motion to dismiss the complaint. In September 2024, Corteva amended its complaint to include additional infringement claims with respect to soybean and corn technologies. In May 2025, the federal court dismissed Inari’s claims of sham litigation, patent misuse, and state-based deceptive trade practices claims. This May 2025 order was amended to reinstate Inari’s estoppel defense. The trial is expected to begin in the second half of 2026.

Source: Item 3, 10-K 0001755672-26-000004 vs Item 3, 10-K 0001755672-25-000005

Accounting Policies73 words changed in this paragraph; it is 62% similar to last year's version.
In the event that a derivative designated as a hedge of a firm commitment or an anticipated transaction is terminated prior to the maturation of the hedged transaction, the net gain or loss in accumulated other comprehensive income (loss) generally remains in accumulated other comprehensive income (loss) until the item that was hedged affects earnings. If a hedged transaction matures, or is sold, extinguished, or terminated prior to the maturity of a derivative designated as a hedge of such transaction, gains or losses associated with the derivative through the date the transaction matured are included in the measurement of the hedged transaction and the derivative is reclassified as for trading purposes. Derivatives designated as hedges of anticipated transactions are reclassified as for trading purposes if the anticipated transaction is no longer probable.

Source: 10-K text, Note 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, 10-K 0001755672-26-000004 vs 10-K text, Note 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, 10-K 0001755672-25-000005

Sentences and paragraphs added, removed or reworded

Every change, by type

Sentences and paragraphs of CTVA's Risk Factors and MD&A, 10-K Feb 12, 2026 against 10-K Feb 14, 2025. Each links to the text at sec.gov.

Quiet changes are sentences kept from last year with one to four words changed, at least one of them a hedge, a modal or a qualifier (may, could, will, not, significant, material…). A year or date rolling forward is not counted.

The full word list

adverse, adversely, all, although, anticipate, anticipates, any, approximately, believe, believes, can, cannot, certain, could, expect, expects, generally, however, if, intend, intends, largely, likely, many, material, materially, may, might, most, must, never, no, not, possible, primarily, probable, should, significant, significantly, some, substantial, substantially, unlikely, will, would

AddedRisk Factors
On December 6, 2025, President Trump issued an executive order titled “Addressing Security Risks from Price Fixing and Anti‑Competitive Behavior in the Food Supply Chain.” The order directs the U.S. Department of Justice ("DOJ") and the U.S. Federal Trade Commission ("FTC") to establish Food Supply Chain Security Task Forces focused on investigating anti‑competitive conduct across food supply sectors, including seeds, and, critically, assessing whether control by foreign entities is increasing US food prices or creating national or economic security risks. While the ultimate impact of the executive order will depend on the actions ultimately resulting from the U.S. regulatory authorities, actions taken by such authorities may increase the regulation and regulatory costs associated with the agriculture industry in the future and restrict the company from pursuing certain growth opportunities, including mergers and acquisitions.
Read it in 10-K Feb 12, 2026 at sec.gov
AddedRisk Factors
Recent funding and staff reductions, including at the EPA, the USDA, the FDA and the U.S. Department of Health and Human Services ("HHS"), could hinder our ability to receive timely regulatory approvals.
Read it in 10-K Feb 12, 2026 at sec.gov
AddedRisk Factors
Corteva’s genetically modified seed products are subject to regulatory oversight under the Coordinated Framework for the Regulation of Biotechnology, which includes the regulatory authority of the USDA addressing plant safety, as well as the authority of the FDA for food and feed safety. Corteva’s pesticidal crop protection products and certain biotechnology developed seed products that express pesticidal traits are also regulated by the EPA to verify that there is no unreasonable adverse effect to the environment. For Corteva’s crop protection products, the EPA is responsible for registering and overseeing the approval and marketing of pesticides, while the USDA and the FDA monitor levels of pesticide residue permitted on or in crops. See "Part I – Item 1 – Business – Regulatory Considerations" of this report for more information on the regulation of our business.
Read it in 10-K Feb 12, 2026 at sec.gov
AddedRisk Factors
Significant staff or funding reductions, along with any extended shutdown of the federal government, may significantly impact the timelines for reviewing our regulatory submissions and re-registrations. Longer-term structural changes at relevant federal agencies, including shifts in enforcement focus, review processes, evidentiary standards and resource allocation, may extend the time it takes to commercialize our products, thereby having a material adverse effect on our business, results of operations, and the value of our intellectual property.
Read it in 10-K Feb 12, 2026 at sec.gov
AddedRisk Factors
Corteva is subject to risks related to its plans to separate its seed and crop protection businesses in a spin-off that will result in two standalone public companies, including that the proposed separation may not be completed on the contemplated timeline or at all and may not achieve the intended benefits.
Read it in 10-K Feb 12, 2026 at sec.gov
AddedRisk Factors
On October 1, 2025, Corteva announced its intent to separate its Seed and Crop Protection businesses into two standalone, publicly traded companies, in a transaction that is intended to qualify as a tax-free spin-off for U.S. federal income tax purposes (the “Proposed Separation”). The Proposed Separation is subject to the satisfaction of a number of customary conditions,
Read it in 10-K Feb 12, 2026 at sec.gov
AddedRisk Factors
including, among others, the filing and effectiveness of a Form 10 registration statement with the SEC, receipt of a tax opinion from external counsel to the effect that, among other things, the transaction will qualify as a tax-free spin-off, and final approval by Corteva’s Board of Directors. The ultimate timing of the Proposed Separation will depend on the readiness of each business to operate as an independent public company and the finalization of appropriate capital structures for each. The failure to satisfy all of the required conditions for the Proposed Separation, as well as unanticipated developments, could delay, prevent or otherwise adversely affect the Proposed Separation. These potential developments, many of which are outside of Corteva’s control, include, but are not limited to, disruptions in general or financial market conditions, material adverse changes in business or industry conditions, unanticipated costs, difficulties or delays in obtaining various regulatory and tax approvals or clearances, and stakeholder actions or challenges relating to the Proposed Separation or to other aspects of Corteva’s business or strategy.
Read it in 10-K Feb 12, 2026 at sec.gov
AddedRisk Factors
Executing the Proposed Separation will require significant time and attention from Corteva’s senior management and employees, which could disrupt Corteva’s ongoing business, negatively impact Corteva’s relationships with employees, suppliers, customers, distributors, licensors and other stakeholders and adversely affect Corteva’s financial results and results of operations. There can be no assurances that Corteva will be able to complete the Proposed Separation on the terms or on the timeline that was announced, if at all, or that the complexities, costs and dis-synergies associated with the Proposed Separation will not be significant or exceed expectations. Moreover, although Corteva expects to maintain an investment grade credit rating, a downgrade in Corteva’s rating may lead to increased borrowing costs for Corteva. In addition, there may be increased borrowing costs associated with the re-allocation or taking on of new debt in connection with the Proposed Separation.
Read it in 10-K Feb 12, 2026 at sec.gov
Show the other 47
AddedRisk Factors
If the Proposed Separation is completed, Corteva may not be able to achieve the full strategic and financial benefits that are expected to result from the Proposed Separation. Following the Proposed Separation, the Seed and Crop Protection businesses will bear the full costs and responsibilities of operating a standalone public company and these dis-synergies may exceed expectations. Moreover, the Seed and Crop Protection businesses will each be smaller, less diversified enterprises, and as a result, the separated companies may be more exposed to industry-specific risks and changing market conditions than Corteva is today. The Proposed Separation also may prompt existing stockholders to divest holdings that no longer align with their investment objectives, potentially affecting the trading value of each company’s common stock following the Proposed Separation. Further, there can be no assurance that the combined value of the common stock of the two companies will be equal to or greater than the value of Corteva’s common stock had the Proposed Separation not occurred.
Read it in 10-K Feb 12, 2026 at sec.gov
AddedRisk Factors
In addition, while it is expected that Corteva will receive a tax opinion from external counsel to the effect that, among other things, the Proposed Separation will qualify as a tax-free spin-off for U.S. federal income tax purposes, any such opinion is not binding on the U.S. Internal Revenue Service. Accordingly, the U.S. Internal Revenue Service may reach conclusions with respect to the Proposed Separation that are different from the conclusion reached in such opinion. If the Proposed Separation is ultimately determined to be taxable, either Corteva or Corteva’s stockholders could incur significant income tax liabilities.
Read it in 10-K Feb 12, 2026 at sec.gov
RemovedRisk Factors
In July 2021, the Biden administration issued an executive order promoting competition in the American economy. The order encouraged further examination and efforts by U.S. regulatory agencies to avoid market concentrations for agricultural inputs, that could challenge the survival of family farms. The executive order also directs the U.S. Secretary of Agriculture to take action to ensure that the intellectual property system, while still incentivizing innovation, does not also unnecessarily reduce competition in seed and other agricultural input markets beyond what is reasonably contemplated by the U.S. Patent Act and propose strategies for addressing those concerns across intellectual property, antitrust, and other relevant laws. While the ultimate impact of the executive order will depend on the actions ultimately resulting from the U.S. regulatory authorities, actions taken by such authorities may increase the regulation and regulatory costs associated with the agriculture industry in the future and restrict the company from pursuing certain growth opportunities, including mergers and acquisitions.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedRisk Factors
EIDP has identified a material weakness in its internal control over financial reporting, which could negatively impact the accurate and timely reporting of its results of operations and financial condition.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedRisk Factors
As described in the EIDP Management's Report on Internal Control over Financial Reporting within this Annual Report on Form 10-K, the management of EIDP identified a material weakness in its internal control over financial reporting with respect to the appropriate classification of the cash flows covering intercompany activities with Corteva, Inc., which resulted in the restatement of EIDP’s Consolidated Statements of Cash Flows within its financial statements for the year ending 2023 and a material misclassification of the Consolidated Statements of Cash Flows for each of the three subsequent quarters in 2024. While EIDP has developed a remediation plan, it will not be able to conclude whether the remediation of the material weakness was successful until sufficient time has passed to allow management to test the design and operational effectiveness of its enhanced controls. Not fully remediating the material weakness or identifying additional control weaknesses, could result in additional accounting errors or reporting delays that may negatively impact a company’s reputation or reduce its stock price.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedRisk Factors
As discussed further in Note 16 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, Corteva is engaging in a dispute resolution process with DuPont related to tax indemnification liabilities and the classification of potential liabilities from certain non-PFAS related disputes. Additional disputes between DuPont and Corteva may arise in the future. If these disputes are not resolved favorably for Corteva, there could be significant impacts to the current carrying value of its indemnification liabilities and cost sharing obligation under the Separation Agreement and the Tax Matters Agreement.
Read it in 10-K Feb 14, 2025 at sec.gov
RewordedRisk Factors
While not there is no anticipated required contribution for 2025, 2026, Corteva may make expects to evaluate making discretionary contributions to the principal U.S. pension plan. plan and/or may be required to make contributions in the future.
Read it in 10-K Feb 12, 2026 at sec.gov
RewordedRisk Factors
These restrictions may make it more difficult, time consuming and/or expensive for Corteva to develop and commercialize certain new products and services, or may result in certain of its products or services being later to market than those of its competitors.
Read it in 10-K Feb 12, 2026 at sec.gov
RewordedRisk Factors
Additionally, Corteva’s ability to export its products and its sales outside the United States has been, and may continue to be adversely affected by significant changes in trade, tax or other policies, including the risk that other countries may retaliate through retaliating by purchasing less from the United States and the imposition of their own trade restrictions and/or increased tariffs in response to substantial changes to U.S. tariff, trade and tax policies, including those being evaluated by the Trump administration. policies.
Read it in 10-K Feb 12, 2026 at sec.gov
RewordedRisk Factors
Future outbreaks or pandemics could negatively impact customer demand and the company's business, financial condition, and results of operations in numerous ways, including but not limited to increased market volatility that impacts the company's hedging, financial forecasting, and liquidity, including its access to capital markets and delays or modifications to the company's strategic plans and productivity initiatives.
Read it in 10-K Feb 12, 2026 at sec.gov
RewordedRisk Factors
Corteva, furthermore, may These contributions could be required to make significant contributions to its pension plans in the future, which could and adversely affect Corteva’s results of operations, liquidity and financial condition.
Read it in 10-K Feb 12, 2026 at sec.gov
RewordedRisk Factors
Furthermore, the length of time and the risk associated with the breeding and biotech pipelines are interlinked because both are required as a package for commercial success in markets where
Read it in 10-K Feb 12, 2026 at sec.gov
RewordedRisk Factors
If a competitor were to successfully establish an intermediary platform for distribution of Corteva’s products, it may disrupt Corteva’s distribution model and inhibit Corteva’s ability to provide a complete go-to-market strategy covering the direct, dealer and retail channels. model.
Read it in 10-K Feb 12, 2026 at sec.gov
RewordedRisk Factors
Risks related to the satisfaction of these indemnification obligations and temporarily bearing losses may be increased if DuPont completes the announced spin-off of its DuPont's electronics business spin-off, Qnity Electronics, Inc., or if other divested businesses of Historical DuPont (including Chemours) or Historical Dow do not or are unable to cover their liabilities or satisfy their indemnification obligations.
Read it in 10-K Feb 12, 2026 at sec.gov
RewordedRisk Factors
In addition, if the execution of these transactions, investments, or portfolio actions is not successful, it could adversely impact Corteva’s financial condition, cash flows and results of operations. operations and cash flows.
Read it in 10-K Feb 12, 2026 at sec.gov
RewordedRisk Factors
In addition, Corteva has seen an increase in recent years in the number of lawsuits filed by those who identify themselves as public or environmental interest groups seeking to invalidate pesticide product registrations registrations, including those for Enlist One®, and/or challenge the way federal or state governmental entities apply the rules and regulations governing pesticide produce use.
Read it in 10-K Feb 12, 2026 at sec.gov
RewordedRisk Factors
The failure to receive necessary permits or approvals approvals, or the invalidation thereof, could have near- and long-term effects on Corteva’s ability to produce and sell some current and future products.
Read it in 10-K Feb 12, 2026 at sec.gov
Quiet changesRisk Factors
If DuPont or Dow, as applicable, fails to fulfill its obligations or chooses to not enforce the licensed patents, trade secrets or know-how under the Intellectual Property Cross-License Agreements, the company may not be able to prevent competitors from making, using and selling competitive products and services.
Read it in 10-K Feb 12, 2026 at sec.gov
AddedMD&A
On October 1, 2025, the company announced its intent to separate its Seed and Crop Protection businesses into two standalone, publicly traded companies, in a transaction that is intended to be a tax-free spin-off for U.S. federal income tax purposes.
Read it in 10-K Feb 12, 2026 at sec.gov
AddedMD&A
(In millions) Balance at December 31, 2023 $ 501 Remediation payments 1 (58) Net increase in remediation accrual 1 42 Net change, indemnification 2 (7) Balance at December 31, 2024 $ 478 Remediation payments 1 (40) Net increase in remediation accrual 1 67 Net change, indemnification 2 57 Balance at December 31, 2025 3 $ 562
Read it in 10-K Feb 12, 2026 at sec.gov
RemovedMD&A
On March 1, 2023, Corteva completed its acquisitions of all the outstanding equity interests in Stoller Group Inc. (“Stoller”), one of the largest independent companies in the Biologicals industry, and Quorum Vital Investment, S.L. and its affiliates (“Symborg”), an expert in microbiological technologies. The purchase price for Stoller and Symborg was $1,220 million, inclusive of a working capital adjustment, and $370 million, respectively. These acquisitions supplement the Crop Protection business with additional biological tools that complement evolving farming practices. See Note 4 - Business Combinations, to the Consolidated Financial Statements, for additional information.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedMD&A
In connection with the company’s shift to a global business unit model during 2022, the company assessed its business priorities and operational structure to maximize the customer experience and deliver on growth and earnings potential. As a result of this assessment, the company committed to restructuring actions during the second quarter of 2022, which included the company’s separate announcement to withdraw from Russia ("Russia Exit") (collectively the “2022 Restructuring Actions”). The actions associated with this program are substantially complete.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedMD&A
prior period. Higher other expense was partially offset by an increase in interest income and the absence of charges incurred in 2022 relating to certain legal matters and losses associated with a previously held equity investment.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedMD&A
operations, financial condition and cash flows. It is the opinion of the company’s management, however, that the possibility is remote that costs in excess of the range disclosed will have a material impact on the company’s results of operations, financial condition or cash flows. For further discussion, see "Environmental Matters" section on page 58 and Note 16 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedMD&A
The company’s Seed segment currently has certain third-party biotechnology trait license agreements, which require up-front and variable payments subject to the licensor meeting certain conditions. These payments are reflected as other current assets and other assets and are amortized to cost of goods sold as seeds containing the respective trait technology are utilized over the term of the license. The rate of royalty amortization expense recognized is based on the company’s strategic plans which include various assumptions and estimates including product portfolio, market dynamics, farmer preferences, growth rates and projected planted acres. Changes in factors and assumptions included in the strategic plans, including potential changes to the product portfolio in favor of internally developed biotechnology, could impact the rate of recognition of the relevant prepaid royalty.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedMD&A
At December 31, 2024, the balance of prepaid royalties reflected in other current assets and other assets was approximately $65 million and $160 million, respectively. Through June 30, 2024, the prepaid royalties balance largely related to the non-exclusive license in the United States and Canada for the Monsanto Company's Genuity® Roundup Ready 2 Yield® glyphosate tolerance trait and Roundup Ready 2 Xtend® glyphosate and dicamba tolerance trait for soybeans, which was obtained by the company’s wholly owned subsidiary, Pioneer Hi-Bred International, Inc. (“Pioneer”) (“Roundup Ready 2 License Agreement”).
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedMD&A
In connection with the departure from these traits in the company's product portfolio in favor of the Enlist E3TM trait platform, beginning January 1, 2020 the company presents and discloses accelerated prepaid royalty amortization expense associated with these prepaid royalties as a component of restructuring and asset related charges - net in the Consolidated Statement of Operations. The accelerated prepaid royalty amortization expense represents the difference between the rate of amortization based on the revised number of units expected to contain the Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® trait technology and the per unit cash rate per the Roundup Ready 2 License Agreement. As of December 31, 2024, the Enlist E3TM trait platform has grown to 65 percent of our soybean portfolio. For the year ended December 31, 2024, the company recognized charges of $55 million in restructuring and asset related charges - net in the Consolidated Statement of Operations from non-cash accelerated prepaid royalty amortization expense, which as of the end of the second quarter of 2024 is complete. For further discussion of accelerated prepaid royalty amortization, refer to Note 2 - Summary of Significant Accounting Policies, to the Consolidated Financial Statements.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedMD&A
Continuing political and social attention to climate change and its impacts has resulted in regulatory and market-based approaches to limit greenhouse gas emissions. The company believes there is a way forward for sustainable climate change mitigation that both enables farmers to meet the demands of a growing population and secures the economic future for the vast majority of the world’s population who depend on agriculture for their livelihoods.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedMD&A
and mitigate the impact of extreme and volatile weather. The company integrates processes for identifying, assessing and managing climate-related risk into its enterprise risk management program.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedMD&A
While Corteva is working to reduce its role in the emission of greenhouse gasses, it also invests in enabling innovation that can create a more resilient agriculture value chain. The company engages with multiple stakeholders and partners around the globe regarding our innovations and actionable ideas to help safeguard the health and well-being of the planet and its people.
Read it in 10-K Feb 14, 2025 at sec.gov
RewordedMD&A
Significant ItemsYear ItemsFor the Year Ended December 31, (In millions) 2025 2024 2023 2022 Restructuring and asset related charges - net $ 146 $ 288 $ 336 $ 363 Bayer resolution 1 610 — — Estimated settlement expense1 expense 2 — 101 204 87 Inventory write-offs2 write-offs 3 — (2) 7 33 Spare parts write-off 3 4 — — 12 — (Gain) loss on sale of business, assets and equity investments2 investments 3,4 (37) (7) (14) (10) Settlement costs associated with the Russia Exit2 — — 8 Seed sale associated with Russia Exit2,4 Exit 3,5 — — (18) (3) Acquisition-related costs5 costs 6 — 6 45 — Employee Retention Credit — — (3) (9) AltEn facility remediation charges 7 37 — 10 33 Insurance proceeds6 proceeds 8 (98) (71) — — Total pre-tax significant items (benefit) charge $ 658 $ 315 $ 579 $ 502 Total tax (benefit) provision impact of significant items7 items 9 (153) (80) (131) (102) Tax only significant item (benefit) charge8 charge 10 77 116 (45) (133) Total significant items (benefit) charge, after tax $ 582 $ 351 $ 403 $ 267
Read it in 10-K Feb 12, 2026 at sec.gov
RewordedMD&A
Reconciliation of Income (Loss) from Continuing Operations after Income Taxes to Operating EBITDAFor the Year Ended December 31, (In millions) 2025 2024 2023 2022 Income (loss) from continuing operations after income taxes (GAAP) $ 1,204 $ 863 $ 941 $ 1,216 Provision for (benefit from) income taxes on continuing operations 484 412 152 210 Income (loss) from continuing operations before income taxes (GAAP) $ 1,688 $ 1,275 $ 1,093 $ 1,426 Depreciation and amortization 1,203 1,227 1,211 1,223 Interest income (136) (132) (283) (124) Interest expense 180 233 233 79 Exchange (gains) losses - net 181 284 397 229 Non-operating (benefits) costs - net 39 174 151 (111) Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges — — — Significant items (benefit) charge 658 315 579 502 Separation costs 35 — — Operating EBITDA (Non-GAAP) $ 3,848 $ 3,376 $ 3,381 $ 3,224
Read it in 10-K Feb 12, 2026 at sec.gov
RewordedMD&A
These items were partially offset by a $(59) $(55) million deferred tax benefit associated with a change in a legal entity’s U.S. tax characterization, a $(47) million benefit related to U.S. tax credits for increasing research activities and $(32) activities, a $(29) million in benefit related to a capital loss (net of valuation allowance), as well as net tax benefits associated with changes to deferred taxes and in accruals for certain prior year tax positions.
Read it in 10-K Feb 12, 2026 at sec.gov
RewordedMD&A
Payments Due In (In millions) Total at 2025 2026 2027 and December 31, 2024 2025 beyond Expected cumulative cash requirements for interest payments $ 459 515 $ 100 89 $ 359 426 through maturity Purchase obligations1 2,242 685 1,557 obligations 1 2,022 821 1,201 License agreements2, agreements 2, 3 207 160 46 161 114 Other liabilities2, liabilities 2, 4 274 41 233 276 44 232 Total 5 $ 3,182 2,973 $ 872 1,000 $ 2,310 1,973
Read it in 10-K Feb 12, 2026 at sec.gov
RewordedMD&A
The $232 Restructuring and asset related charges - net were $146 million for the year ended December 31, 2025, which was primarily comprised of a $150 million charge associated with the Crop Protection Operations Strategy Restructuring Program was primarily comprised consisting of $91 $11 million of severance and related benefit costs, $101 $13 million of asset related charges, $10 $60 million in decommissioning and demolition costs and $30 $66 million of contract termination charges.
Read it in 10-K Feb 12, 2026 at sec.gov
RewordedMD&A
COGS was $9,172 million (53 percent of net sales) for the year ended December 31, 2025 compared to $9,529 million (56 percent of net sales) for the year ended December 31, 2024 compared to $9,920 million (58 percent of net sales) for the year ended December 31, 2023. 2024.
Read it in 10-K Feb 12, 2026 at sec.gov
RewordedMD&A
The company completed the 2021 2022 Share Buyback Plan during the first second quarter of 2023 2025 and repurchased and retired 4,098,000, 17,425,000 7,815,000, 17,909,000 and 5,572,000 10,026,000 shares in the open market and through privately-negotiated transactions for a total cost (excluding excise taxes) of $250 $500 million, $1 billion, billion and $250 $500 million during the years year ended December 31, 2025, 2024 and 2023, 2022 and 2021, respectively.
Read it in 10-K Feb 12, 2026 at sec.gov
RewordedMD&A
The company completed the 2021 2022 Share Buyback Plan during the first second quarter of 2023 2025 and repurchased and retired 4,098,000, 17,425,000 7,815,000, 17,909,000 and 5,572,000 10,026,000 shares in the open market and through privately-negotiated transactions for a total cost (excluding excise taxes) of $250 $500 million, $1 billion, billion and $250 $500 million during the years ended December 31, 2025, 2024 and 2023, 2022 and 2021, respectively.
Read it in 10-K Feb 12, 2026 at sec.gov
RewordedMD&A
R&D expense was $1,474 million (8 percent of net sales) for the year ended December 31, 2025 and $1,402 million (8 percent of net sales) for the year ended December 31, 2024 and $1,337 million (8 percent of net sales) for the year ended December 31, 2023. 2024.
Read it in 10-K Feb 12, 2026 at sec.gov
RewordedMD&A
The increase in R&D expense is in support of the company’s company's long-term growth plans and was primarily driven by an increase in salaries higher employee compensation costs due to higher headcount, variable compensation increases, as well as higher contractor, consulting and contractor costs, partially offset by favorable currency impacts. field, lab and facilities costs.
Read it in 10-K Feb 12, 2026 at sec.gov
RewordedMD&A
SG&A expenses were $3,492 million (20 percent of net sales) for the year ended December 31, 2025 and $3,196 million (19 percent of net sales) for the year ended December 31, 2024 and $3,176 million (18 percent of net sales) for the year ended December 31, 2023. 2024.
Read it in 10-K Feb 12, 2026 at sec.gov
RewordedMD&A
The decrease was primarily driven by favorable currency effects, ongoing cost and productivity actions, Crop Protection raw material deflation, and a reduction in net royalty expense, partially lower commodity prices and raw material deflation, with a partial offset by an increase in volumes and from higher commodity costs. volumes.
Read it in 10-K Feb 12, 2026 at sec.gov
Quiet changesMD&A
About Approximately 85 percent of total pre-tax environmental operating costs charged to income (loss) from continuing operations for the year ended December 31, 2024 2025 resulted from operations in the U.S.
Read it in 10-K Feb 12, 2026 at sec.gov

Sources

The two latest 10-Ks on EDGAR, section by section. Each change links to the text at sec.gov.

Also

New risk factors: paragraphs with nothing like them last year, quoted in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CTVA/export.csv") into a cell.

Next:Related parties
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.